JOHN KIRKWOOD to Myeloproliferative Disorders
This is a "connection" page, showing publications JOHN KIRKWOOD has written about Myeloproliferative Disorders.
Connection Strength
0.060
-
Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group. Cancer. 2003 Jul 01; 98(1):100-9.
Score: 0.049
-
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen. Cancer. 1981 May 15; 47(10):2414-21.
Score: 0.011